BRD4, a Bromodomain and Extraterminal (BET) protein family member, is a promising anti-cancer drug target. However, resistance to BET inhibitors targeting BRD4 is common in solid tumors. Here, we show that cancer-associated fibroblast (CAF)-activated stromal signaling, interleukin-6/8-JAK2, induces BRD4 phosphorylation at tyrosine 97/98 in colorectal cancer, resulting in BRD4 stabilization due to interaction with the deubiquitinase UCHL3. BRD4 phosphorylation at tyrosine 97/98 also displays increased binding to chromatin but reduced binding to BET inhibitors, resulting in resistance to BET inhibitors. We further show that BRD4 phosphorylation promotes interaction with STAT3 to induce chromatin remodeling through concurrent binding to enhancers and super-enhancers, supporting a tumor-promoting transcriptional program. Inhibition of IL6/IL8-JAK2 signaling abolishes BRD4 phosphorylation and sensitizes BET inhibitors in vitro and in vivo. Our study reveals a stromal mechanism for BRD4 activation and BET inhibitor resistance, which provides a rationale for developing strategies to treat CRC more effectively.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295257PMC
http://dx.doi.org/10.1038/s41467-021-24687-4DOI Listing

Publication Analysis

Top Keywords

brd4 phosphorylation
20
bet inhibitors
16
brd4
9
chromatin remodeling
8
bet inhibitor
8
inhibitor resistance
8
colorectal cancer
8
cancer brd4
8
resistance bet
8
bet
7

Similar Publications

Article Synopsis
  • RNA is essential for forming nuclear compartments, with phosphatidylinositol 4,5-bisphosphate (PIP2) playing a key role in RNA transcription and localization in these compartments.
  • The study identified the RNA-dependent PIP2-associated (RDPA) nuclear proteome, revealing that proteins in this group often have intrinsically disordered regions that can bind to PIP2 and possess modification sites.
  • Highlighting the relationship between PIP2 and RNA, the research found that the protein BRD4 interacts with PIP2 in an RNA-dependent manner, suggesting that PIP2 is crucial for organizing nuclear processes necessary for gene expression.
View Article and Find Full Text PDF

Flipping a switch on BRD4: How to control the do-it-all.

Mol Cell

November 2024

Science for Life Laboratory, Stockholm, Sweden; Department of Gene Technology, KTH Royal Institute of Technology, Stockholm, Sweden. Electronic address:

In this issue, Devaiah et al. identify JNK-catalyzed phosphorylation to convert bromodomain-containing protein 4 (BRD4) from a chromatin regulator to a transcription activator.

View Article and Find Full Text PDF

Ferroptosis has emerged as a critical mechanism in the development and progression of various tumors, particularly diffuse large B-cell lymphoma (DLBCL). However, the thorough characterization of ferroptosis-related genes in DLBCL remains inadequately explored. We retrieved datasets associated with DLBCL and ferroptosis gene sets from the Gene Expression Omnibus (GEO) database and the Ferroptosis Database (FerrDb), resulting in the identification of 27 differentially expressed ferroptosis-related genes (DE-FRGs) linked to DLBCL.

View Article and Find Full Text PDF

Phosphorylation by JNK switches BRD4 functions.

Mol Cell

November 2024

Experimental Immunology Branch, NCI, NIH, Bethesda, MD 20892, USA. Electronic address:

Bromodomain 4 (BRD4), a key regulator with pleiotropic functions, plays crucial roles in cancers and cellular stress responses. It exhibits dual functionality: chromatin-bound BRD4 regulates remodeling through its histone acetyltransferase (HAT) activity, while promoter-associated BRD4 regulates transcription through its kinase activity. Notably, chromatin-bound BRD4 lacks kinase activity, and RNA polymerase II (RNA Pol II)-bound BRD4 exhibits no HAT activity.

View Article and Find Full Text PDF
Article Synopsis
  • Age-related susceptibility to sepsis involves hyperactive immune systems and changes in macrophages, which show chronic inflammation and a dysfunctional response to pathogens.
  • In older mice, a cytokine called GDF3 increases inflammatory responses in adipose tissue macrophages (ATMs) during endotoxemia, leading to more CD11c+ ATMs and inflammatory cytokines.
  • Targeting the GDF3-SMAD2/3 signaling pathway can reduce inflammation and improve outcomes in older organisms, suggesting it could be a potential therapeutic target for age-related inflammation issues.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!